Table 1.
CSF* | Oral Phe loading test Phe/Tyr ratio |
Enzyme activity GTPCH in fibroblasts |
Molecular diagnosis Sequencing GCH1 |
||||||
---|---|---|---|---|---|---|---|---|---|
5-HIAA (nmol/L) |
HVA (nmol/ L) |
Neopterin (nmol/L) |
Biopterin (nmol/L) |
1h | 2h | 4h | |||
Index case | 173 | 318 | 3 | 8 | 6.6** | 5.9** | 2.2** | 0.39 µU/mg | c.235_240delCTG AGC [p.L79_S80del] |
Ref. values (child) | 87–366 | 158–596 | 9–55 | 10–52 | 1.6–5.4 | 0.9–2.8 | 0.6–1.5 | 22 % enzyme activity of normal controls | |
Mother | 7.7 | 8.2 | 2.8 | c.235_240delCTG AGC [p.L79_S80del] | |||||
Father | 5.1 | 2.6 | 1.4 | Negative | |||||
Ref. values (adult) | 2–6.3 | 1.17– 4.15 | 0.6– 1.88 |
CSF = cerebrospinal fluid, Phe = phenylalanine, Tyr = tyrosine, 5-HIAA = 5-hydroxyindoleacetic acid, HVA = homovanilic acid, GTPCH = guanosine triphosphate cyclohydrolase I
CSF was collected five days after discontinuation of treatment with levodopa.
Described as patient 14 in the reference by López-Laso et al. [11]